Qcm Cayman, Ltd. Dexcom Inc Transaction History

Qcm Cayman, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$67.99 - $132.89 $28,419 - $55,548	-418 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$94.08 - $130.2 $39,325 - $54,423	418 New	418 $214,000
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $57,826 - $71,432	-682 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $53,196 - $71,269	682 New	682 $252,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.